Chargement

Slzii.com Recherche

Recherche (Nouvelles)

Tangram Therapeutics Announces First Participant Dosed In Phase 1/2 RESTORE-MASH Trial Of TGM-312, A Novel Investigational Rnai Medicine

health top

(MENAFN - GlobeNewsWire - Nasdaq) Phase 1/2 RESTORE-MASH trial will evaluate safety, pharmacokinetics, and pharmacodynamics of TGM-312 in healthy volunteers and MASH patients Initial data ...
2026-03-05 08:16:33

Que fais-tu?
0.074615001678467


Nouvelles
Nouvelles

Dernières nouvelles et titres
(MENAFN - GlobeNewsWire - Nasdaq) Phase 1/2 RESTORE-MASH trial will evaluate safety, pharmacokinetics, and pharmacodynamics of TGM-312 in he...
Nouvelles